The hierarchical model of NAFLD: Prognostic significance of histologic features in NASH

Gastroenterology

Volumn 149, Issue 2, 2015, Pages 278-281

  Loomba, Rohit ^a   Chalasani, Naga ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL BLEEDING; AGE; ASCITES; CLINICAL TRIAL (TOPIC); DEATH; DIABETES MELLITUS; DISEASE COURSE; FOLLOW UP; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER TRANSPLANTATION; MORTALITY; NONALCOHOLIC FATTY LIVER; PATTERN RECOGNITION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SMOKING; TREATMENT RESPONSE; UNITED STATES; FEMALE; LIVER; MALE; PATHOLOGY;

FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE;

EID: 84938150863     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.06.016     Document Type: Editorial

References (13)

1. C.D. Williams, J. Stengel, M.I. Asike, and et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study Gastroenterology 140 2011 124 131
2. R. Loomba, and A.J. Sanyal The global NAFLD epidemic Nat Rev Gastroenterol Hepatol 10 2013 686 690
3. N. Chalasani, Z. Younossi, J.E. Lavine, and et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology Gastroenterology 142 2012 1592 1609
4. C.A. Matteoni, Z.M. Younossi, T. Gramlich, and et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 1999 1413 1419
5. S. Singh, A.M. Allen, Z. Wang, and et al. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies Clin Gastroenterol Hepatol 12 2015 643 654
6. L.A. Adams, J.F. Lymp, J. St Sauver, and et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study Gastroenterology 129 2005 113 121
7. M. Ekstedt, L.E. Franzen, U.L. Mathiesen, and et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes Hepatology 44 2006 865 873
8. D.E. Kleiner, E.M. Brunt, M. Van Natta, and et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321
9. P. Angulo, D.E. Kleiner, S. Dam-Larsen, and et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease Gastroenterology 149 2015 389 397
10. L.M. Stinton, and R. Loomba Recommendations for liver biopsy evaluation in non-alcoholic fatty liver disease Minerva Gastroenterol Dietol 60 2014 5 13
11. Z.M. Younossi, M. Stepanova, N. Rafiq, and et al. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality Hepatology 53 2011 1874 1882
12. M. Ekstedt, H. Hagstrom, P. Nasr, and et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up Hepatology 61 2015 1547 1554
13. A.J. Sanyal, S.L. Friedman, A.J. McCullough, and L. Dimick-Santos Challenges and opportunities in drug and biomarker development in nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases - U.S. Food and Drug Administration joint workshop Hepatology 61 2015 1392 1405